Interferon as treatment for acute hepatitis C: A meta-analysis

Digestive Diseases and Sciences

Volumn 41, Issue 6, 1996, Pages 1248-1255

  Cammà, Calogero ^a   Almasio, Piero ^b   Craxì, Antonio ^b  

^a Ist di Med Generale e Pneumologia   (Italy)

^b NONE

Author keywords

Acute hepatitis; HCV RNA; Interferon; Meta analysis

Indexed keywords

BETA INTERFERON; INTERFERON;

ACUTE HEPATITIS; ARTICLE; HEPATITIS C; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; META ANALYSIS; PRIORITY JOURNAL;

ACUTE DISEASE; ADULT; CONTROLLED CLINICAL TRIALS; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; INTERFERON-ALPHA; INTERFERON-BETA; MALE; MIDDLE AGED; RNA, VIRAL;

EID: 0029893886     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02088245     Document Type: Article

References (55)

1. Alter MJ, Margolis HS, Krawczynski K, Judson FN, Marcs A, Alexander WJ, Hu PY, Miller JK, Gerber MA, Sampliner RE, Meeks EL, Beach MJ: The natural history of community-acquired hepatitis C in the United States. N Engl J Med 327:1899-1905, 1992
2. Tremolada F, Casarin C, Tagger A, Rihero ML, Realdi G, Alberti A, Ruol A: Antibody to hepatitis C virus in post-transfusion hepatitis. Ann Intern Med 114:277-281, 1991
3. Giuberti T, Marin MG, Ferrari C, Marchelli S, Schianchi C, Degli Antoni AM, Pizzocolo G, Fiaecadori F: Hepatitis C virus viremia following clinical resolution of acute hepatitis C. J Hepatol 20:666-671, 1994
4. Alter HJ: Chronic consequences of non-A, non-B hepatitis. In Current Perspective in Hepatology. LB Seef, JH Lewis (eds). New York, Plenum Publishing, 1989, pp 83-97
5. Papevangelou G, Tassopoulos N, Roumeliotou-Karayannis A, Richardson C: Etiology of fulminant viral hepatitis in Greece. Hepatology 4:369-372, 1994
6. Tassopoulos N, Hatzakis A, Delladetsima I. Koutelou MG, Todoulos A, Miriagou V: Role of hepatitis C virus in acute non-A, non-B hepatitis in Greece: A five year prospective study. Gastroenterology 102:969-972, 1992
7. Bortolotti F, Tagger A, Cadrobbi P, Crivellaro C, Pregliasco F, Ribero ML, Alberti A: Antibodies to hepatitis C virus in community-acquired acute non-A, non-B hepatitis. J Hepatol 12:176-180, 1991
8. Realdi G, Alberti A, Rugge M: Long term follow-up of acute and chronic non A non B post transfusion hepatitis:evidence of progression to liver cirrhosis. Gut 23:270-275, 1992
9. Genesca J, Estehan JL, Alter HJ: Blood-borne non-A, non-B hepatitis: hepatitis C. Semin Liver Dis 11:147-164, 1991
10. Simonetti RG, Cammà C, Fiorello F, Cottone M, Rapicetta M, Marino L, Fiorentino G, Craxi A, Ciccaglione A, Giuseppetti R, Stroffolini T, Pagliaro L: Hepatitis C infection as a risk factor tor hepatocellular carcinoma in Patients with cirrhosis: A case-control study. Ann Intern Med 116:97-102, 1992
11. Lee SD, Tsai YT, Hwang SJ, Wu JC, Yung CH, Cheng KK, Lo KJ: A prospective study of posttransfusion non-A, non-B hepatitis (type C) hepatitis following cardiovascular surgery in Taiwan. J Med Virol 33:188-92, 1991
12. Tremolada F, Casarin C, Alberti A, Drago G, Tagger A, Rihero ML, Realdi G: Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitis. J Hepatol 16:273-281, 1942
13. Dienstig JL, Alter HJ: Non-A, non-B hepatitis: Evolving epidemiologic and clinical perspective. Semin Liver Dis 6:67-81, 1986
14. Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer HC, Perrillo RP, Carey W, Jacobson IM, Payne J, Dienstag JL, Van Thiel DH, Tamburro C, Lefkowitch J, Albrecht J, Meschievitz C, Ortego TJ, Cibas A: Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized controlled trial. N Hngl J Med 321:1501-1506, 1989
15. Di Bisceglie AM, Martin P, Kassianides C, Lisker-Melman M, Murray L, Waggoner J, Goodman Z, Banks S, Hoofnagle JH: Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double blind, placebo-controlled trial. N Engl J Med 321:1506-1510, 1989
16. Tinè F, Magrin S, Craxì A, Pagliaro L: Interferon for non-A, non-B chronic hepatitis: a metanalysis of randomized clinical trials. J Hepatol 13:192-199, 1991
17. Pagliaro L, Craxì A, Cammà C, Tinè F, Di Marco V, Lo Iacono O, Almasio P: Interferon-α for chronic hepatitis C: an analysis of pretreatment clinical predictors of response. Hepatology 15:820-828, 1994
18. Causse X, Godinot H, Chevallier M, Chossegros P, Zoulin F, Ouzan D, Heyraud JP, Fontanges T, Albrecht J. Meschievitz C, Trepo C: Comparison of 1 or 3 MU of Interferon alfa-2b and placebo in patients with chronic non-A, non-B hepatitis. Gastroenterology 101:497-502, 1991
19. Weiland O, Schvarcz R, Wejstal R, Norkrans G, Fryden A: Therapy of chronic post-transfusion non-A, non-B hepatitis with interteron alfa-2b: Swedish experience. J Hepatol 11 (suppl 1):s57-s62, 1990
20. 2b in patients with acute transfusion-associated hepatitis C. Hepatology 19:19-22, 1994
21. Viladomiu L, Genescà J, Esteban JI, Allende H, Gonzàlez A, Lòpez-Talavera LC, Esteban R, Guardia J: Interferon-α in acute posttransfusion hepatitis C: A randomized, controlled trial. Hepatology 15:767-769, 1992
22. Hwang S-J, Lee S-D, Chan C-Y, Lu R-H, Lo K-J: A randomized controlled trial of recombinant interferon α-2b in the treatment of Chinese patients with acute post-transfusion hepatitis C. J Hepatol 21:831-836, 1994
23. Takano S, Satomura Y, Omata M, Japan Acute Hepatitis Coop Study Group: Effects of interferon beta on non-A, non-B acute hepatitis: A prospective, randomized, controlled-dose study. Gastroenterology 107:805-811, 1994
24. Tassopoulos NC, Koutelou MG, Papatheodoridis G, Polychronaki H, Delladetsima I, Giannikakis T, Todoulos A, Toliopoulos A, Hatzakis A: Recombinant human interferon alfa-2b treatment for acute non-A, non-B hepatitis. Gut 34(Suppl):S130-S132, 1993
25. Ohnishi K, Nomura F, Nakano M: Interferon therapy for acute posttransfusion non-A, non-B hepatitis: Response with respect to anti-hepatitis C virus antibody status. Am J Gastroenlerol 86:1041-1049, 1991
26. Ohnishi K, Nomura F, Iida S: Treatment of posttransfusion non-A, non-B hepatitis acute and chronic hepatitis with human fibroblast β-interferon: A preliminary report. Am J Gastroenterol 84:596-600. 1989
27. Hagiwara H, Hayashi N, Kasahara A, Mita E, Takehara T, Fusamoto H, Kamada T. Three cases of posttransfusion hepatitis C treated with interferon-α. Confirmation of a carrier state by detection of hepatitis C virus RNA after interferon therapy. Dig Dis Sci 37:631-634, 1992
28. Almasio P, Mirto S, Malleo C, Di Marco V, Caronia F, Craxi A: Recombinant interferon alpha-2B for acute post-transfusion hepatitis in acute myeloid leukemia. Haematologica 76:429-430, 1991
29. Omata M, Yokosuka O, Takano S, Kato N, Hosoda K, Imazeki F, Tada M, Ito Y, Ohto M: Resolution of acute hepatitis C after therapy with natural beta interferon. Lancet 338:914-915, 1991
30. Tassopoulos NC, Koutelou M, Papatheodoridis G, Polychronaki H, Giannikakis T, Paraloglou-Ioannides M, Hatzakis A: Treatment of acute non-A, non-B hepatitis with interferon alpha-2b. Infection 20:242, 1992
31. Genesca J, Estcban JI, Quer J, Viladomiu L, Gonzàlez A, Estehan R, Guardia J: Hepatitis C virus markers in patients with acute post-transfusion hepatitis treated with interferon alfa-2b. Gut 34(suppl):S62-S63, 1993
32. Palmovic D, Kurelac I, Crnjakovic-Palmovic J: The treatment of acute post-transfusion hepatitis C with recombinant interferon-alpha. Infection 22:222-223, 1994
33. Alberli A, Belussi F, Chemello L, Benvegnù L, Pontisso P: Outcome of acute hepatitis C and role of interferon alpha (IFN-2a) therapy. Proceedings of the International Symposium on Viral Hepatitis and Liver Disease. Tokyo, May 10-14, 1993
34. Viladomiu L, Lopez-Talavera JC, Gonzalez A, Esteban JI, Esteban R, Guardia J: Interferon treatment in acute posttransfusion NANB hepatitis. J Hepatol 11(suppl 1):S166, 1990
35. Viladomiu L, Gonzàlez A, Lòpez-Talavera LC, Estcban JI, Esteban R, Guardia J: Randomized controlled study of recombinant alpha-interferon therapy in acute post-transfusion hepatitis. International Symposium on Viral Hepatitis and Liver Disease. Houston, 1990, p 178
36. Colombo M, Lampertico P, Rumi M: Multicentre randomised controlled trial of recombinant interferon alfa-2b in patients with acute non-A, non-B/type C hepatitis after transfusion. Gut 34(suppl):S141, 1993
37. 2b in patients with acute post-transfusion non-A, non-B hepatitis (PTH). Gastroenterology 102:A838, 1992
38. Chemello L, Benvegnu L, Bellusi F, Tagger A, Ruol A, Alberti A: Pilot study of interferon alpha-2a therapy in preventing chronic evolution of acute hepatitis C. J Hepatol 11(suppl 2):S81, 1992
39. Alberti A, Chemello L, Benvegnù L, Bellusi F, Tagger A, Ruol A: Pilot study of interferon alpha-2a therapy in preventing chronic evolution of acute hepatitis C. International Symposium on Viral Hepatitis and Liver Disease. Houston, 1990, p 176 (abstract)
40. Omata M, Takano S: Interferon treatment for acute hepatitis C. International Symposium on Viral Hepatitis and Liver Disease, Tokyo, 1993, p 44 (abstract)
41. Vogel W, Umlauft F, Datz C, Judmaier G, Schneider G, Grünewald K: High dose interferon alpha for acute hepatitis C. Hepatology 18(Pt 2):89A, 1993
42. Germanaud J, Causse X, Dhumeaux D: Transmission de l'hépatite C lors de piqûres accidentelles. Evaluation du risque. Presse Med 1994;23:1078-1082.
43. Pawlotsky JM, Marcellin P, Trepo C, Dhumeaux D: Treatment of viral hepatitis C. Gastroenterol Clin Biol 18(4):362-373, 1994
44. Esteban R: Is there a role for interferon in acute viral hepatitis. Gut 34(suppl):S77-S80, 1993
45. Rakela J, Douglas DD: Therapy of acute hepatitis C with interferon: How good is it really. Hepatology 16:497-498, 1992
46. Gross JB: Selected summaries: Interferon-α in acute posttransfusion hepatitis C: A randomized, controlled trial. Gastroenterology 103:1702-1703, 1992
47. Sacks HS, Berrier J, Reitman D, Ancona-Berk VA, Chalmers TC: Meta-analyses of randomised controlled trials. N Engl J Med 316:450-455, 1987
48. DerSimonian R, Laird N: Meta-analysis in clinical trials. Controlled Clin Trials 7:177-188, 1986
49. Mantel N, Haenszel W: Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719-748, 1959
50. Collins R, Scrimgeour A, Yusuf D, Phil D, Peto R: Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin: Overview of results of randomized trials in general orthopedic and urologic surgery. N Engl J Med 5:1162-1173, 1988
51. Berlin JA, Laird NM, Sacks HS, Chalmers TC. A comparison of statistical methods for combining rates from clinical trials. Stat Med 8:141-151, 1989
52. Chalmers TC, Smith H, Blackburn B, Silverman B, Schroeder B: A method for assessing the quality of a randomized trial. Controlled Clin Trials 2:31-49, 1981
53. Nicolucci A, Grilli R, Alexanian AA, Apolone G, Torri V, Liberati A: Quality, evolution, and clinical implications of randomized, controlled trials on the treatment of lung cancer: A lost opportunity for meta-analysis. JAMA 262:2101-2107, 1989
54. Alter HJ: Transfusion transmitted hepatitis C and non-A, non-B, non-C. Vox Sang 67(suppl 3): 19-24, 1994
55. Diamond GA, Denton AT: Alternative perspectives on the biased foundations of medical technology assessment. Ann Intern Med 118:455-464, 1993